Cargando…
Impacts of neoadjuvant therapy on the number of dissected lymph nodes in esophagogastric junction cancer patients
BACKGROUND: Neoadjuvant therapy favors the prognosis of various cancers, including esophagogastric junction cancer (EGC). However, the impacts of neoadjuvant therapy on the number of dissected lymph nodes (LNs) have not yet been evaluated in EGC. METHODS: We selected EGC patients from the Surveillan...
Autores principales: | Wang, Qi, Ge, Jin-tong, Wu, Hua, Zhong, Sheng, Wu, Qing-quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999651/ https://www.ncbi.nlm.nih.gov/pubmed/36894903 http://dx.doi.org/10.1186/s12876-023-02705-7 |
Ejemplares similares
-
Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction
por: Cai, Ming-Zhi, et al.
Publicado: (2019) -
Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: Erratum
Publicado: (2017) -
Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma
por: Lee, In-Seob, et al.
Publicado: (2017) -
Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma
por: Liang, Rong, et al.
Publicado: (2022) -
Impact of Solitary Involved Lymph Node on Outcome in Localized Cancer of the Esophagus and Esophagogastric Junction
por: O’Riordan, James M., et al.
Publicado: (2007)